Literature DB >> 21933150

Aplasia Ras homologue member I overexpression induces apoptosis through inhibition of survival pathways in human hepatocellular carcinoma cells in culture and in xenograft.

Xin-Hong Pei1, Zhen Yang, Hong-Xiang Liu, Shi-Shi Qiao.   

Abstract

The aim of the present study was to determine the effects of ARHI (aplasia Ras homologue member I; also known as DIRAS3), a member of the Ras superfamily, on HCC (hepatocellular carcinoma) cells and to define the molecular pathways involved. Stable transfection of ARHI into the HCC cell line Hep3B that lacks expression of this gene reduced cell proliferation significantly as compared with the transfection of empty vector (P<0.01). Moreover, the re-expression of ARHI induced significant apoptosis, whereas a few vector transfectants or non-transfected cells displayed apoptosis. Mechanistically, ARHI restoration impeded the activation of both Akt (also called protein kinase B) and NF-κB (nuclear factor κB). In vivo, restoring ARHI also exerted suppressive effects on xenograft tumour growth, which was coupled with increased apoptosis. Together, these results indicate that ARHI has pro-apoptotic effects on HCC cells, which is associated with the inactivation of both Akt and NF-κB survival pathways.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21933150     DOI: 10.1042/CBI20110023

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  3 in total

1.  Somatic Mutation of ARHI Gene in Hepatocellular Carcinomas.

Authors:  Chang Jae Kim; Jung Woo Shin; Seok Won Jung; Bo Ryung Park; Neung Hwa Park
Journal:  Pathol Oncol Res       Date:  2015-07-05       Impact factor: 3.201

2.  Effects of ARHI on breast cancer cell biological behavior regulated by microRNA-221.

Authors:  Ying Li; Mei Liu; Yanjun Zhang; Chun Han; Junhao You; Junlan Yang; Cheng Cao; Shunchang Jiao
Journal:  Tumour Biol       Date:  2013-06-26

3.  The expression of aplysia ras homolog I (ARHI) and its inhibitory effect on cell biological behavior in esophageal squamous cell carcinoma.

Authors:  Yuqiang Mao; Yun Han; Wenjun Shi
Journal:  Onco Targets Ther       Date:  2017-02-27       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.